Short-term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in Female Patients
OnabotulinumtoxinA administered at a dose of 100 U was well-tolerated and resulted in significant and clinically meaningful improvements in the OAB symptoms and HRQoL of patients whose OAB could not be adequately managed with other treatments.
Authors
- Hirotaka Sato (ORCID: https://orcid.org/0000-0002-8321-9731)
- Shota Otsuka (ORCID: https://orcid.org/0000-0002-2232-8387)
- Sachiyuki Tsukada (ORCID: https://orcid.org/0000-0002-1186-5232)
- Takahiro Watanabe (ORCID: https://orcid.org/0000-0002-7249-8106)
Institutions
- Kinan Hospital (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-02-26
- DOI
- https://doi.org/10.21873/invivo.13899
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00